Evidence map›Paper›PMID 19539012›Full record

ReviewBiochimica et biophysica acta2009

The TOR pathway comes of age.

Monique N Stanfel, Lara S Shamieh, Matt Kaeberlein, Brian K Kennedy

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 188 papers.

0numbers the graph read from it
0cells of the map it votes in
188citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

188 citing papers in PubMed, 330 citations in OpenAlex.

  1. Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: A pilot single-arm trial.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  2. Evolutionary genetics of ageing.Nature reviews. Genetics · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. International journal of molecular sciences · 2022
    Article
  12. Review
  13. Review
  14. Review
  15. We are all aging, and here's why.Aging medicine (Milton (N.S.W)) · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Frontiers in nutrition · 2022
    Article
  20. Review

128 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Monique N StanfelDepartment of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Lara S Shamieh
Matt Kaeberlein
Brian K Kennedy
University of Washington · US

Funding

GENETIC APPROACHES TO AGING RESEARCHT32AG000057 · NIA · UNIVERSITY OF WASHINGTON · PI RABINOVITCH, PETER S · 1985 to 2019
$14.2M
Mechanisms of Life Span Extension By Dietary DeprivationR01AG031108 · NIA · UNIVERSITY OF WASHINGTON · PI KAEBERLEIN, MATT, VAN GILST, MARC R · 2008 to 2019
$3.2M
TOR, Translation and AgingR01AG033373 · NIA · UNIVERSITY OF WASHINGTON · PI KENNEDY, BRIAN K · 2009 to 2013
$1.8M
Genome-wide Analysis of Aging in YeastR01AG025549 · NIA · UNIVERSITY OF WASHINGTON · PI KENNEDY, BRIAN K · 2006 to 2010
$1.5M
NIA NIH HHS R01 AG025549NIA NIH HHS R01AG025549-04NIA NIH HHS R01 AG031108NIA NIH HHS R01AG031108NIA NIH HHS R01AG033373-01A1NIA NIH HHS T32AG000057
6 · The paper itself

Abstract

Studies in a variety of model organisms indicate that nutrient signaling is tightly coupled to longevity. In nutrient replete conditions, organisms develop, grow, and age quickly. When nutrients become sparse as with dietary restriction, growth and development decline, stress response pathways become induced and organisms live longer. Considerable effort has been devoted to understanding the molecular events mediating lifespan extension by dietary restriction. One central focus has been on nutrient-responsive signal transduction pathways including insulin/IGF-1, AMP kinase, protein kinase A and the TOR pathway. Here we describe the increasingly prominent links between TOR signaling and aging in invertebrates. Longevity studies in mammals are not published to date. Instead, we highlight studies in mouse models, which indicate that dampening the TOR pathway leads to widespread protection from an array of age-related diseases.

Indexed as

Signal TransductionAgingAnimalsDrosophila ProteinsHumansMiceModels, BiologicalNeoplasmsPhosphatidylinositol 3-KinasesProtein KinasesTOR Serine-Threonine KinasesDrosophila ProteinsMTOR protein, humanmTOR protein, mousePhosphatidylinositol 3-KinasesProtein Kinasestarget of rapamycin protein, DrosophilaTOR Serine-Threonine Kinases

Identifiers

PMID19539012
PMCPMC3981532
OpenAlexW2147501289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.